Turning Point Therapeutics Inc. (TPTX) PT Raised to $130 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Matthew Biegler raised the price target on Turning Point Therapeutics Inc. (NASDAQ: TPTX) to $130.00 (from $120.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
